Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis—are we there yet? Authors' reply

Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis—are we there yet? Authors' reply

LINKED CONTENT This article is linked to Sorda et al papers. To view these articles, visit https://doi.org/10.1111/apt.16618 and https://doi.org/10.1111/apt.16657

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alimentary pharmacology & therapeutics 2022-01, Vol.55 (2), p.249-250
Hauptverfasser: Sorda, Juan Antonio, González Ballerga, Esteban, Barreyro, Fernando Javier, Daruich, Jorge
Format: Artikel
Sprache:eng
Schlagworte:
Bezafibrate
Bezafibrate - therapeutic use
Cholangitis
Cholangitis - chemically induced
Cholangitis - drug therapy
Humans
Liver Cirrhosis, Biliary - drug therapy
Ursodeoxycholic Acid
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:LINKED CONTENT This article is linked to Sorda et al papers. To view these articles, visit https://doi.org/10.1111/apt.16618 and https://doi.org/10.1111/apt.16657
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.16726